1.Influence of tumor size on chemosensitivity of FSa II in combination of cyclophosphamide and radiation.
Woong Ki CHUNG ; Hyon De CHUNG ; Sung Whan HA ; Charn Il PARK
Journal of the Korean Cancer Association 1992;24(1):109-124
No abstract available.
Cyclophosphamide*
2.Suppression of Photocontact Hypersensitivity by Suberythemal Doses of UVB Irradiation and Its Reversal by Low Dose of Cyclophosphamide.
Sung Woo CHOI ; Chong Ha LIM ; Eun Jung CHYUNG ; Won HOUH
Korean Journal of Dermatology 1984;22(1):41-46
No abstract available.
Cyclophosphamide*
;
Hypersensitivity*
3.An experimental study on enhanced antitumor effect of cyclophosphamide by methylxanthines human gastric cancer cells(NUGC-4).
Jae Jun KIM ; Min Hyuk LEE ; Kyung Bal HUR
Journal of the Korean Cancer Association 1992;24(4):469-479
No abstract available.
Cyclophosphamide*
;
Humans*
;
Stomach Neoplasms*
4.Effect of intravenous pulse cyclophosphamide in the treatment of Churg-Strauss syndrome with refractory neuropathy to high-dose steroid treatment.
Young Hee LIM ; Sang Pyo LEE ; Eun Mi KOH ; Dong Chull CHOI
Journal of Asthma, Allergy and Clinical Immunology 2000;20(1):113-121
No abstract available.
Churg-Strauss Syndrome*
;
Cyclophosphamide*
5.Exploration on biological effects of methionyl-glycyl-funtumin
Pharmaceutical Journal 1999;274(2):15-17
Preliminary investigation of methionyl-glycyl-funtumin (MGF) in experimental immunodeficiency model using Cyclophosphamide (CY) showed that MGF did not to have an immunostimulant activity at the dose of 30g/kg. A potent toxicity of CY has been observed when associated with MGF in the model. The result could help to further study on this subject
Cyclophosphamide
;
Biological Sciences
6.Modulatory effect of water and/or food deprivation, and cyclophosphamide administration on immune response in mice.
Tai You HA ; Won Jae SONG ; Jeong Ho LEE
Korean Journal of Immunology 1992;14(1):53-62
No abstract available.
Animals
;
Cyclophosphamide*
;
Food Deprivation*
;
Mice*
7.Modulatory effect of water and/or food deprivation, and cyclophosphamide administration on immune response in mice.
Tai You HA ; Won Jae SONG ; Jeong Ho LEE
Korean Journal of Immunology 1992;14(1):53-62
No abstract available.
Animals
;
Cyclophosphamide*
;
Food Deprivation*
;
Mice*
8.Interstitial lung disease associated with polymyositis:response to cyclophosphamide and prednisolone combination treatment.
Jong Ho MOON ; Jun Young PARK ; Sang Moo LEE ; Hyeon Tae KIM ; Soo Taek UH ; Yeon Tae CHUNG ; Yong Hoon KIM ; Choon Sik PARK ; Kyung Soo LEE
Tuberculosis and Respiratory Diseases 1993;40(2):197-202
No abstract available.
Cyclophosphamide*
;
Lung Diseases, Interstitial*
;
Prednisolone*
9.Immunosuppressed model for experimental mice by cyclophosphamid
Journal of Vietnamese Medicine 2004;296(3):57-60
Study on white mices with age of 6-8 weeks, 18-20g body weight. They were divided into 3 groups: group 1 (control group): 30 mices; group 2: mices were immunesuppressed by 200mg cyclophosphamid per one kilogram of body weight, being checked after 5 days of injection; and 300mg cyclophosphamid per one kilogram (200mg on the first day and 100mg on the fifth day) and it was checked after 10 days of injection (group 3). The results: immunesuppressed model implemented by intraperitonial injection of 200mg per one kilogram of body weight checked after 5 days of injeciton. These parameters were used to assign the immune function
Immunosuppressive Agents
;
Mice
;
Animal Experimentation
;
Cyclophosphamide
10.Bevacizumab and oral metronomic cyclophosphamide in platinum-resistant ovarian cancer.
Journal of Gynecologic Oncology 2013;24(3):209-211
No abstract available.
Antibodies, Monoclonal, Humanized
;
Bevacizumab
;
Cyclophosphamide
;
Ovarian Neoplasms
Result Analysis
Print
Save
E-mail